GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Total Liabilities (2009 - 2026)

Updated

Gsk's Total Liabilities came in at $59.79 billion for the quarter ended Jun 30, 2026, down 0.2% from $59.9 billion a year earlier and down 2.4% from the prior quarter.

Analysis

Gsk (GSK) Total Liabilities (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk's Total Liabilities was $59.55 billion, up 0.4% from the prior year.

  • Total Liabilities carries a five-year compound annual growth rate of -4.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Total Liabilities was $59.28 billion in the year ended Dec 31, 2024 (+3.1%), $57.48 billion in the year ended Dec 31, 2023 (-7.2%), $61.94 billion in the year ended Dec 31, 2022 (-22.1%) and $79.47 billion in the year ended Dec 31, 2021 (+3.8%).
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Total Liabilities since the quarter ended Mar 31, 2025.
  • Year-over-year, Total Liabilities increased in six of the last eight quarters, with growth averaging 2.4%.
  • The fastest year-over-year change in Total Liabilities over five years came in the quarter ended Mar 31, 2023 (growth of 135.7%), and the weakest in the quarter ended Mar 31, 2022 (a decline of 69.0%).
  • Business Quant data shows GSK's Total Liabilities at $61.27 billion (quarter ended Mar 31, 2026), $60.07 billion (quarter ended Dec 31, 2025) and $61.51 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 116.09 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 141.05 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 65.46 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 37.53 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 115.64 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 59.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.79 Bn
Mar 31, 2026 61.27 Bn
Dec 31, 2025 60.07 Bn
Sep 30, 2025 61.51 Bn
Jun 30, 2025 59.90 Bn
Mar 31, 2025 59.26 Bn
Dec 31, 2024 59.52 Bn
Sep 30, 2024 57.94 Bn
Jun 30, 2024 55.91 Bn
Mar 31, 2024 57.44 Bn
Dec 31, 2023 57.35 Bn
Sep 30, 2023 61.11 Bn
Jun 30, 2023 59.19 Bn
Mar 31, 2023 57.47 Bn
Dec 31, 2022 58.71 Bn
Sep 30, 2022 60.81 Bn
Jun 30, 2022 83.62 Bn
Mar 31, 2022 24.39 Bn
Dec 31, 2021 77.86 Bn
Sep 30, 2021 78.50 Bn
API Access

Gsk Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=GSK&period=max&api_key=YOUR_API_KEY